HMG CoA Reductase Inhibitor-Induced Myotoxicity: Pravastatin and Lovastatin Inhibit the Geranylgeranylation of Low-Molecular-Weight Proteins in Neonatal Rat Muscle Cell Culture-Reference-Cited by-同舟云学术

HMG CoA Reductase Inhibitor-Induced Myotoxicity: Pravastatin and Lovastatin Inhibit the Geranylgeranylation of Low-Molecular-Weight Proteins in Neonatal Rat Muscle Cell Culture

Published:1997-07 Issue:1 Volume:145 Page:99-110
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Flint Oliver P.,Masters Barbara A.,Gregg Richard E.,Durham Stephen K.

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference41 articles.

1. Mevalonate controls cytoskeleton organization and cell morphology in thyroid epithelial cells;Bifulco;J. Cell Physiol.,1993

2. Massive rhabdomyolysis and simvastatin;Bizzaro;Clin. Chem.,1992

3. Simvastatin-induced rhabdomyolysis followed by a melas syndrome;Chariot;Am. J. Med.,1993

4. Rhabdomyolysis due to combined treatment with lovastatin and cholestyramine;Chrysanthopoulos;BMJ,1992

5. Lovastatin/gemfibrozil myopathy: A clinical, histochemical, and ultrastructural study;Churallah;Eur. Neurol.,1992

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interindividual variability in statin pharmacokinetics and effects of drug transporters;Expert Opinion on Drug Metabolism & Toxicology;2024-01-22

2. Revolutionizing hyperlipidemia treatment: Nanoencapsulated CoQ10 and selenium combat simvastatin-induced myopathy and insulin resistance in rats;Advanced Pharmaceutical Bulletin;2023-09-23

3. Alleviation of hyperlipidemia, insulin resistance, and myopathy by nano selenium/ nano CoQ10 platform with simvastatin in hyperlipidemic rats; comprehensive outlook;2023-01-03

4. The Role of Nutraceutical Supplements, Monacolin K and Astaxanthin, and Diet in Blood Cholesterol Homeostasis in Patients with Myopathy;Biomolecules;2022-08-14

5. Mechanisms of statin-associated skeletal muscle-associated symptoms;Pharmacological Research;2020-04